Dr Stefaan Verbruggen
BEng, PhD, FHEA

 
Dr Stefaan Verbruggen

Lecturer in Medical Technology

Engineering 224, Mile End

ResearcherID ORCID Google Scholar LinkedIn Twitter/X

Feedback/
support hours:
In Person - Tuesdays - 10-11am - ENG Room 224
Online - Thursdays - 1-2pm - Microsoft Teams
(copy booking link into browser: https://shorturl.at/R3WZ8)
Expertise: Bone biomechanics and mechanobiology, Developmental biomechanics, cancer mechanobiology
Research Centre:Bioengineering
Affiliations: Queen Mary+Emulate Organs-on-Chips Centre
Centre for Predictive in vitro Models
Organ-on-a-chip Technologies Network

Visiting Academic, INSIGNEO Institute for in silico Medicine

Fellow of the Higher Education Academy
Member of the UK Biomedical Engineering Association
Member of the European Society of Biomechanics
Member of the Orthopaedic Research Society
Member of the European Association for Cancer Research
Member of the European Organ-on-a-Chip Society

Brief Biography

Dr Stefaan Verbruggen is a Lecturer in Medical Technology at Queen Mary University of London. His research focuses on the mechanobiology of bone cells, and developing predictive in vitro models of cancer metastasis. As a Visiting Academic at the INSIGNEO Institute of in silico Medicine, Dr Verbruggen also builds predictive computational models of the biomechanics of metastatic bone lesions.

Prior to this, Dr Verbruggen conducted his PhD research in bone cell mechanobiology the Biomechanics Research Centre at the National University of Ireland Galway, followed by postdoctoral research in how fetal movements affect joint development in the Developmental Biomechanics Lab at Imperial College London.
Dr Verbruggen was then awarded a Marie Sklodowska-Curie Research Fellowship at Queen Mary University of London. As part of a collaboration with the Department of Biomedical Engineering at Columbia University, New York, Dr Verbruggen's investigated the mechanobiology of cancer cells, and how they metastasise to bone from other areas of the body.